CRRL-094

N/A

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameCRRL-094
Drug Alias Nameinsulin-secreting natriuretic peptide (Mayo clinic)CRRL-094
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAtrial natriuretic peptide receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsAtrial natriuretic peptide receptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A